OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint ...

One of the original pioneers in cell and gene therapy, OXB has more than 25 years of experience in viral vectors ... expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other ...

This makes them ideal for treating genetic disorders and chronic diseases. Unlike AAV, which provides episomal (non-integrating) gene expression, lentiviral vectors are more suitable for therapies ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

The AAV Innovation Summit 2025, hosted by Form Bio, will bring together top experts in gene therapy to discuss the latest ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...